Day: February 18, 2022

VANCOUVER, British Columbia, Feb. 18, 2022 (GLOBE NEWSWIRE) — North Arrow Minerals Inc. (TSXV-NAR) (“North Arrow”) announces that it has agreed with Anglo Celtic Exploration Ltd (“Anglo Celtic”) to extend by one year the term of an unsecured loan of $400,000 (the “Loan”) provided to North Arrow and first announced on February 17, 2021. Under terms of the amendment to the loan agreement (the “Agreement”) the revised date by which any outstanding balance on the loan must be repaid in full is February 16, 2023. All other terms related to the Loan and the Agreement remain the same. As further consideration for agreeing to extend the Loan, North Arrow shall issue to Anglo Celtic 1,000,000 share purchase warrants (the “Bonus Warrants”). Each Bonus Warrant will allow Anglo Celtic to purchase one common share (a “Warrant Share”) at a price...

MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has lifted its clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States. COVAXIN™ is a whole-virion inactivated COVID-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades. “We are pleased to be able to move our clinical program for COVAXIN™ forward, which we hope will bring us closer to offering an alternative COVID-19 vaccine,” said Dr. Shankar Musunuri,...

– Unprecedented monotherapy activity via macrophage reprogramming in preclinical models – – Phase 1 study expected to begin in 1H 2022 – CAMBRIDGE, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science’s journal, Science Advances. exoASO™-STAT6 is a novel, engineered exosome precision medicine candidate in development for the treatment of macrophage-rich tumors. This publication details the findings from the preclinical development...

Nokia CorporationStock Exchange Release18 February 2022 at 21:00 EET Nokia Corporation: Repurchase of own shares on 18.02.2022 Espoo, Finland – On 18 February 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 244,696 5.07CEUX 19,997 5.07AQEU 3,147 5.09TQEX 2,060 5.11Total 269,900 5.07* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the current authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in traches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation...

Dallas, Texas, Feb. 18, 2022 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) has launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp. PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp. Yesterday, the U.S. Department of Agriculture (USDA) published the first ever survey on the newly legal hemp industry.  The report drew on over 20,000 surveyed growers. PURA anticipates generating at least $1 million in revenue in 2022 with the potential to reach $10 million in revenue.  The $10 million revenue opportunity outlook is improving based on the recent progress of PURA’s co-op partners. PURA is scheduled...

ANNOUNCEMENT NO. 45 – 18 FEBRUARY 2022 18 February 2022 Notice is hereby given that the annual general meeting will convene in Dampskibsselskabet NORDEN A/Sat 2.00 p.m. CET on Thursday 24 March 2022, at the Copenhagen Marriott Hotel, meeting room Vesterhavet I, Kalvebod Brygge 5, 1560 Copenhagen V The Annual General Meeting will be held as a hybrid general meeting allowing for either physical or electronic participation. After the general meeting NORDEN will host a canapé reception. AGENDA:         A.        The Board of Directors’ report on the activities of the Company during the past year.         B.        Resolution for adoption of the audited Annual Report.                                 C.        Proposed appropriation of profits or cover of loss in accordance with the adopted annual report.                         D.         Election...